These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22929823)

  • 1. Our experience of coronary angiography with and without heparin.
    Datta G; Dasbiswas A; Bannerjee A; Majumder B; Sarkar A; Mukherjee D
    Indian Heart J; 2012; 64(4):394-6. PubMed ID: 22929823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries.
    Tomaru T; Nakamura F; Aoki N; Sakamoto Y; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):133-44. PubMed ID: 8897062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 1,400 cases of coronary artery angiography without heparin].
    Wang YQ; Wang Y; Cai BN; Liu WH; Chen SL; Dong JZ; He SH; Wen HM; Xiao CB
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1429-31. PubMed ID: 16305973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventions.
    Joost A; Kurowski V; Radke PW
    Curr Pharm Des; 2008; 14(12):1176-85. PubMed ID: 18473864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis.
    Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S
    Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can enoxaparin safely replace unfractionated heparin during coronary intervention in acute coronary syndromes?
    Wolak A; Ayzenberg Y; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2004 Aug; 96(2):151-5. PubMed ID: 15262028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access-site complications after rescue percutaneous coronary intervention during thrombolysis for acute myocardial infarction.
    Germing A; Lindstaedt M; Ulrich S; Bojara W; Lawo T; Mügge A; Grewe P
    Z Kardiol; 2005 Jan; 94(1):23-7. PubMed ID: 15668826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative coronary thrombosis with aprotinin in the prebypass period.
    Myles PS; Esmore DS
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):558-60. PubMed ID: 17678784
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple distal coronary artery thrombosis in acute myocardial infarction: a rare presentation.
    Mahajan K; Batra A; Gupta A; Singla V
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30042110
    [No Abstract]   [Full Text] [Related]  

  • 10. CABG without using heparin in a patient with heparin-induced thrombocytopenia.
    Altop S; Yildirim T; Selimoglu O; Nail Omeroglu S; Oguş T
    J Card Surg; 2006; 21(3):298-300. PubMed ID: 16684068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and intermediate-term clinical outcomes following Heparin coated BX coronary stent implantation in patients with thrombus containing lesions.
    Madduri J; Assali A; Solodky A; Teplizky I; Shor N; Battler A; Kornowski R
    Int J Cardiovasc Intervent; 2004; 6(2):77-81. PubMed ID: 15385206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different dose of heparin in preventing radial artery occlusion after transradial coronary angiography: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Pang Y; Zhang H; Li Y; Zheng Q; Li F
    Medicine (Baltimore); 2020 Nov; 99(46):e23227. PubMed ID: 33181707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fibrinolytic therapy in acute myocardial infarction. Coronarographic evaluation of short-term results].
    Pompei G; Romani F; Nardini M; Zennaro RG; Canossi G
    Radiol Med; 1986 Sep; 72(9):632-6. PubMed ID: 3763965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction.
    Tubaro M; Mattioli G; Matta F; Cappello C; Natale E; Ricci R; Gerardi P; Milazzotto F
    Cardiovasc Drugs Ther; 1993 Nov; 7(5):809-16. PubMed ID: 8110625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.
    Mehran R; Aymong ED; Ashby DT; Fischell T; Whitworth H; Siegel R; Thomas W; Wong SC; Narasimaiah R; Lansky AJ; Leon MB
    Circulation; 2003 Sep; 108(9):1078-83. PubMed ID: 12925457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin versus unfractionated heparin for residual thrombus burden: a frequency-domain optical coherence tomography study.
    Vergallo R; Joye R; Barlis P; Jia H; Tian J; Soeda T; Minami Y; Hu S; Dauerman HL; Toma C; Chan J; Lee H; Biasucci LM; Crea F; Jang IK
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):575-82. PubMed ID: 25115992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin and calcium heparin in thrombosis prophylaxis in patients with percutaneous arterial and venous ports for colorectal liver metastases.
    Zanon C; Bortolini M; Chiappino I
    Tumori; 2005; 91(6):477-80. PubMed ID: 16457145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.
    Shahzad A; Kemp I; Mars C; Wilson K; Roome C; Cooper R; Andron M; Appleby C; Fisher M; Khand A; Kunadian B; Mills JD; Morris JL; Morrison WL; Munir S; Palmer ND; Perry RA; Ramsdale DR; Velavan P; Stables RH;
    Lancet; 2014 Nov; 384(9957):1849-1858. PubMed ID: 25002178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary intervention with a heparin-coated stent and aspirin only.
    Ruygrok PN; Sim KH; Chan C; Rachman OJ; Adipranoto JD; Trisnohadi HB; Stewart JT; Ahmad N; Mak KH; Yusak M; Boestan I; Santoso T; Suryapranata H
    J Invasive Cardiol; 2003 Aug; 15(8):439-41. PubMed ID: 12890872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention.
    Busch G; Steppich B; Sibbing D; Braun SL; Stein A; Groha P; Schömig A; Kastrati A; von Beckerath N; Ott I
    Thromb Haemost; 2009 Feb; 101(2):340-4. PubMed ID: 19190819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.